| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 21,7 k € | -18.7% | 26,7 k € | -4.8% | 28,1 k € | -4.6% | 29,4 k € | +144.6% | 12,0 k € | -44.9% | 21,8 k € | +6.3% | 20,5 k € | +5.6% | 19,4 k € | -47.9% | 37,4 k € | +13.0% | 33,1 k € | +38.1% | 23,9 k € | -13.7% | 27,7 k € | -3.1% | 28,6 k € | -26.2% | 38,8 k € | -18.9% | 47,9 k € | +12.5% | 42,6 k € | -5.8% | 45,2 k € | -34.4% | 68,9 k € | +37.9% | 49,9 k € | |
| EBITDA | 5,2 k € | -44.0% | 9,4 k € | -19.6% | 11,6 k € | -13.2% | 13,4 k € | +403.8% | -4,4 k € | -176.0% | 5,8 k € | +19.4% | 4,9 k € | -0.1% | 4,9 k € | -78.2% | 22,4 k € | +68.4% | 13,3 k € | +78.2% | 7,5 k € | -31.8% | 10,9 k € | -17.8% | 13,3 k € | -40.7% | 22,4 k € | -20.6% | 28,2 k € | +1.9% | 27,7 k € | -7.0% | 29,8 k € | -44.8% | 54,0 k € | +47.3% | 36,6 k € | |
| Operating profit | -787,3 € | -1244.9% | -58,5 € | -102.6% | 2,2 k € | -44.3% | 4,0 k € | +140.1% | -10,0 k € | -533.1% | 2,3 k € | +154.6% | -4,2 k € | +2.5% | -4,3 k € | -204.0% | 4,2 k € | +23.2% | 3,4 k € | +140.0% | -8,4 k € | -529.6% | -1,3 k € | -284.5% | 727,3 € | -92.2% | 9,3 k € | +162.9% | 3,5 k € | -74.0% | 13,5 k € | -11.7% | 15,3 k € | -61.2% | 39,6 k € | +358.9% | 8,6 k € | |
| Profit/loss | 244,4 € | +175.4% | -324,2 € | -117.6% | 1,8 k € | -44.2% | 3,3 k € | +131.7% | -10,4 k € | -802.2% | 1,5 k € | +128.5% | -5,2 k € | +6.6% | -5,6 k € | -282.0% | 3,1 k € | +18.9% | 2,6 k € | +124.6% | -10,4 k € | -281.4% | -2,7 k € | -222.5% | -849,1 € | -169.5% | 1,2 k € | -86.5% | 9,0 k € | +49.0% | 6,1 k € | -53.8% | 13,1 k € | -46.5% | 24,5 k € | +726.1% | 3,0 k € | |
| Equity | 178,9 k € | +0.1% | 178,6 k € | -0.2% | 178,9 k € | +1.0% | 177,1 k € | +1.9% | 173,8 k € | -5.6% | 184,2 k € | +0.8% | 182,7 k € | -2.8% | 187,9 k € | -2.9% | 193,4 k € | +1.6% | 190,4 k € | +1.4% | 187,8 k € | -5.3% | 198,3 k € | -1.4% | 201,0 k € | -0.4% | 201,9 k € | +0.6% | 200,6 k € | +4.7% | 191,6 k € | +3.3% | 185,5 k € | +7.6% | 172,4 k € | +16.6% | 147,9 k € | |
| Total assets | 191,9 k € | -4.5% | 201,0 k € | +1.3% | 198,4 k € | -10.8% | 222,3 k € | +2.5% | 216,9 k € | +11.3% | 194,9 k € | -4.5% | 204,0 k € | -6.7% | 218,8 k € | -4.1% | 228,0 k € | +7.3% | 212,5 k € | -2.0% | 216,8 k € | -0.5% | 218,0 k € | -5.5% | 230,6 k € | -5.5% | 244,0 k € | -7.1% | 262,7 k € | +18.7% | 221,4 k € | +0.5% | 220,3 k € | +3.6% | 212,8 k € | +2.2% | 208,1 k € | |
| Cash | 2,9 k € | -74.9% | 11,5 k € | +76.8% | 6,5 k € | -39.1% | 10,7 k € | +9.1% | 9,8 k € | -58.7% | 23,7 k € | +24.3% | 19,1 k € | -18.4% | 23,4 k € | +29.0% | 18,1 k € | -36.8% | 28,7 k € | +5.8% | 27,1 k € | -27.0% | 37,1 k € | +19.7% | 31,0 k € | -9.4% | 34,2 k € | +129.9% | 14,9 k € | -36.7% | 23,5 k € | +21.3% | 19,4 k € | +145.6% | 7,9 k € | -21.4% | 10,0 k € | |
| Debts | 13,1 k € | -41.5% | 22,4 k € | +15.1% | 19,4 k € | -57.0% | 45,2 k € | +5.0% | 43,1 k € | +303.0% | 10,7 k € | -49.8% | 21,3 k € | -31.0% | 30,9 k € | -10.7% | 34,6 k € | +56.4% | 22,1 k € | -23.7% | 29,0 k € | +47.2% | 19,7 k € | -33.4% | 29,6 k € | -29.9% | 42,2 k € | -32.0% | 62,1 k € | +108.5% | 29,8 k € | -14.5% | 34,8 k € | -13.8% | 40,4 k € | -33.0% | 60,2 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | 0,5 | |||||||||||||||||||
Source: Belgian Official Gazette
Private limited company · Binche · incorporated on 27/08/1992
Private limited company profitable and well capitalised. Cash position declining (-74.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOCTEURS VETERINAIRES WIARD - DUFOUR is a Private limited company incorporated in 1992. Its main activity is: Veterinary activities. Its registered office is in Binche.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.